Skip to main content

Advertisement

ADVERTISEMENT

Hidradenitis Suppurativa News

News
01/18/2022
In their recent trials, researchers examined the tolerability of Janus kinase 1 inhibitor INCB054707, and evaluated efficacy measures including HS Clinical Response.
In their recent trials, researchers examined the tolerability of Janus kinase 1 inhibitor INCB054707, and evaluated efficacy measures including HS Clinical Response.
In their recent trials,...
01/18/2022
The Dermatologist

Advertisement

News
12/16/2021
Drug survival was comparable between the biologics adalimumab, infliximab, and ustekinumab when used as a treatment in patients with hidradenitis suppurativa.
Drug survival was comparable between the biologics adalimumab, infliximab, and ustekinumab when used as a treatment in patients with hidradenitis suppurativa.
Drug survival was comparable...
12/16/2021
The Dermatologist
News
12/08/2021
Prior to this study, the authors had observed that there was a dissociation between pain and number of HS lesions with increasing age.
Prior to this study, the authors had observed that there was a dissociation between pain and number of HS lesions with increasing age.
Prior to this study, the authors...
12/08/2021
The Dermatologist
News
11/03/2021
While pediatric patients with hidradenitis suppurativa (HS) experience similar disease symptoms and course as adult patients, preventive measures should focus on obesity and smoking.
While pediatric patients with hidradenitis suppurativa (HS) experience similar disease symptoms and course as adult patients, preventive measures should focus on obesity and smoking.
While pediatric patients with...
11/03/2021
The Dermatologist

Advertisement

News
09/24/2021
Pediatric patients with hidradenitis suppurativa (HS) have high rates of physical and psychosocial comorbidities, according to a recent study in Pediatric Dermatology. Researchers aimed to describe physical and psychosocial comorbidities...
Pediatric patients with hidradenitis suppurativa (HS) have high rates of physical and psychosocial comorbidities, according to a recent study in Pediatric Dermatology. Researchers aimed to describe physical and psychosocial comorbidities...
Pediatric patients with...
09/24/2021
The Dermatologist
News
08/25/2021
Pediatric patients with HS are more likely utilize emergency services during their journey to receiving a diagnosis than adult patients.
Pediatric patients with HS are more likely utilize emergency services during their journey to receiving a diagnosis than adult patients.
Pediatric patients with HS are...
08/25/2021
The Dermatologist
News
08/16/2021
Patients with HS undergo a variety of treatments, but pain is still poorly controlled and the disease is often misdiagnosed.
Patients with HS undergo a variety of treatments, but pain is still poorly controlled and the disease is often misdiagnosed.
Patients with HS undergo a...
08/16/2021
The Dermatologist

Advertisement

News
08/06/2021
Genetics play a large role in hidradenitis suppurativa (HS) susceptibility, according to a recent study published in British Journal of Dermatology.
Genetics play a large role in hidradenitis suppurativa (HS) susceptibility, according to a recent study published in British Journal of Dermatology.
Genetics play a large role in...
08/06/2021
The Dermatologist
News
07/13/2021
Women with hidradenitis suppurativa who are planning pregnancy or are currently pregnant should receive coordinated care by dermatologists and obstetrical providers due to increased probability of complications.
Women with hidradenitis suppurativa who are planning pregnancy or are currently pregnant should receive coordinated care by dermatologists and obstetrical providers due to increased probability of complications.
Women with hidradenitis...
07/13/2021
The Dermatologist
News
07/11/2021
Flare outbreaks in patients with hidradenitis suppurativa (HS) are a predictive factor of response to adalimumab according to researchers out of Italy.
Flare outbreaks in patients with hidradenitis suppurativa (HS) are a predictive factor of response to adalimumab according to researchers out of Italy.
Flare outbreaks in patients with...
07/11/2021
The Dermatologist

Advertisement

Advertisement